BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 23199282)

  • 21. Pharmacogenetics of schizophrenia.
    Reynolds GP; Templeman LA; Godlewska BR
    Expert Opin Pharmacother; 2006 Aug; 7(11):1429-40. PubMed ID: 16859426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Planning for the optimal design of studies to personalize antipsychotic prescriptions in the post-CATIE era: the clinical and pharmacoepidemiological data suggest that pursuing the pharmacogenetics of metabolic syndrome complications (hypertension, diabetes mellitus and hyperlipidemia) may be a reasonable strategy.
    de Leon J; Diaz FJ
    Schizophr Res; 2007 Nov; 96(1-3):185-97. PubMed ID: 17618085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research.
    Blanc O; Brousse G; Meary A; Leboyer M; Llorca PM
    Fundam Clin Pharmacol; 2010 Apr; 24(2):139-60. PubMed ID: 19702693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics.
    Nnadi CU; Malhotra AK
    Curr Psychiatry Rep; 2007 Aug; 9(4):313-8. PubMed ID: 17880863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalized antipsychotic treatment: the adverse effects perspectives.
    Plesnicar BK
    Psychiatr Danub; 2010 Jun; 22(2):329-34. PubMed ID: 20562775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics and cognitive symptoms in schizophrenia patients treated with antipsychotics.
    Musil R; Spellmann I
    Pharmacogenomics; 2018 Aug; 19(12):927-930. PubMed ID: 30028229
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications.
    Lee AK; Bishop JR
    Pharmacogenomics; 2011 Jul; 12(7):999-1016. PubMed ID: 21787190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetics of psychotropic drug response.
    Malhotra AK; Murphy GM; Kennedy JL
    Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics in psychosis.
    Collier DA
    Drug News Perspect; 2003 Apr; 16(3):159-65. PubMed ID: 12819814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of pharmacogenetics on the development and use of antipsychotic drugs.
    Reynolds GP
    Drug Discov Today; 2007 Nov; 12(21-22):953-9. PubMed ID: 17993414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenomics can improve antipsychotic treatment in schizophrenia.
    Xu Q; Wu X; Xiong Y; Xing Q; He L; Qin S
    Front Med; 2013 Jun; 7(2):180-90. PubMed ID: 23606027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetics and schizophrenia.
    Foster A; Miller DD; Buckley PF
    Psychiatr Clin North Am; 2007 Sep; 30(3):417-35. PubMed ID: 17720030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candidate gene studies of antipsychotic drug efficacy and drug-induced weight gain.
    Malhotra AK
    Neurotox Res; 2004; 6(1):51-6. PubMed ID: 15184105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetics and antipsychotic treatment response.
    Naumovska Z; Nestorovska AK; Filipce A; Sterjev Z; Brezovska K; Dimovski A; Suturkova LJ
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):53-67. PubMed ID: 26076775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals.
    Theisen FM; Hinney A; Brömel T; Heinzel-Gutenbrunner M; Martin M; Krieg JC; Remschmidt H; Hebebrand J
    Psychiatr Genet; 2004 Sep; 14(3):139-42. PubMed ID: 15318026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of pharmacogenetics in a clozapine treatment resistant patient: a case report.
    Sangüesa E; Cirujeda C; Concha J; Padilla PP; Ribate MP; García CB
    Pharmacogenomics; 2019 Aug; 20(12):871-877. PubMed ID: 31453772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetics of dopamine receptors and response to antipsychotic drugs in schizophrenia--an update.
    Scharfetter J
    Pharmacogenomics; 2004 Sep; 5(6):691-8. PubMed ID: 15335289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics of clozapine response and induced weight gain: A comprehensive review and meta-analysis.
    Gressier F; Porcelli S; Calati R; Serretti A
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):163-185. PubMed ID: 26792444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics and antipsychotics in the light of personalized pharmacotherapy.
    Mihaljević-Peles A; Sagud M; Bozina N; Zivković M; Jovanović N
    Psychiatr Danub; 2010 Jun; 22(2):335-7. PubMed ID: 20562776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.
    Need AC; Keefe RS; Ge D; Grossman I; Dickson S; McEvoy JP; Goldstein DB
    Eur J Hum Genet; 2009 Jul; 17(7):946-57. PubMed ID: 19156168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.